Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a minor metadata change and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page no longer displays the government funding lapse notice and associated operating status information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedNo significant changes detected on the Study Details page; the study overview, objectives, eligibility criteria, and plan appear unchanged. Any minor formatting differences are not considered impactful.SummaryDifference0.4%

- Check75 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference2%

- Check82 days agoChange Detected- Terminology updated: 'Clear cell renal carcinoma' replaced with 'Clear cell carcinoma of kidney'. - Version bumped from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check97 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.